Burlingame, CA, United States of America

Kyra Wells

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cala Health, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyra Wells: Innovator in Neuromodulation Technology

Introduction

Kyra Wells is a talented inventor based in Burlingame, CA (US). She has made significant contributions to the field of neuromodulation, showcasing her innovative spirit and dedication to advancing medical technology. With a focus on improving patient outcomes, Kyra has developed a unique patent that reflects her expertise and vision.

Latest Patents

Kyra holds a patent for a "Neuromodulator and band set," which represents a breakthrough in the treatment of various neurological conditions. This invention aims to enhance the effectiveness of neuromodulation therapies, providing patients with improved options for managing their health.

Career Highlights

Kyra is currently employed at Cala Health, Inc., a company known for its commitment to developing innovative solutions in neuromodulation. Her work at Cala Health has positioned her as a key player in the industry, contributing to the company's mission of transforming patient care through technology.

Collaborations

Throughout her career, Kyra has collaborated with notable colleagues, including Gregory T. Schulte and Dustin Bouch. These partnerships have allowed her to leverage diverse expertise and drive forward-thinking projects in the field of neuromodulation.

Conclusion

Kyra Wells is a pioneering inventor whose work in neuromodulation technology is making a significant impact on healthcare. Her dedication to innovation and collaboration continues to inspire advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…